MetaModix's Unattributed - V Round

MetaModix raised a round of funding on March 28, 2017.

Metamodix is dedicated to reducing the human and financial costs of Type 2 Diabetes. The company is developing a drug-free, nonsurgical therapy with the goal of eliminating symptoms and reducing weigh…

Articles about MetaModix's Unattributed - V Round: